Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Knoll develops potential new antipsychotic agent with advantages over available therapies

Nov. 10, 1998

LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects

Nov. 10, 1998

NK1 antagonist L-732138 exhibits activity indicating efficacy in neuropathic pain

Nov. 10, 1998

Novel sodium channel blocker from Roche evaluated in vitro for neuroprotective efficacy

Nov. 10, 1998

Reversible mixed MAO-A/MAO-B inhibitor discovered at Synthelabo is presented this week

Nov. 10, 1998

RPR-118723: a novel anticonvulsant and potent glycine-site NMDA receptor antagonist

Nov. 10, 1998

Pfizer presents preclinical profile of potent, full 5-HT1D receptor antagonist

Nov. 10, 1998

Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders

Nov. 10, 1998

Noncytotoxic thiocolchicine derivatives useful as muscle relaxants

Nov. 10, 1998

Compounds acting on metabotropic glutamate receptors disclosed by Lilly

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...